Teriparatid Each dose of the solution in FORSTEO pre-filled pen contains 20 micrograms (mcg) of teriparatide. Each 1 milliliter (ml) solution for injection contains 250 micrograms of teriparatide. FORSTEO contains the active ingredient teriparatide, which is used to strengthen bones and reduce the risk of fracture by stimulating bone formation. FORSTEO is a clear and colorless solution that is applied under the skin (subcutaneous use). The cartridge in the ready-to-use disposable pen contains 2.4milliliters of solution, sufficient for 28 doses. This product is used in the treatment of osteoporosis. Osteoporosis is a disease that causes your bones to weaken and become brittle. This disease is particularly common in postmenopausal women, but can also develop in men. Osteoporosis is also common in patients using corticosteroids. FORSTEO, in men and women at high risk of fracture, continuous use of oral or injectable glucocorticoids (prednisone 5 mg/day for at least three months) It is also used in the treatment of osteoporosis associated with the use of other corticosteroids at equivalent doses). Using FORSTEO with food and drink, FORSTEO can be used on an empty or full stomach.
- Teriparatid Each dose of the solution in FORSTEO pre-filled pen contains 20 micrograms (mcg) of teriparatide. Each 1 milliliter (ml) solution for injection contains 250 micrograms of teriparatide. FORSTEO contains the active ingredient teriparatide, which is used to strengthen bones and reduce the risk of fracture by stimulating bone formation. FORSTEO is a clear and colorless solution that is applied under the skin (subcutaneous use). The cartridge in the ready-to-use disposable pen contains 2.4milliliters of solution, sufficient for 28 doses. This product is used in the treatment of osteoporosis. Osteoporosis is a disease that causes your bones to weaken and become brittle. This disease is particularly common in postmenopausal women, but can also develop in men. Osteoporosis is also common in patients using corticosteroids. FORSTEO, in men and women at high risk of fracture, continuous use of oral or injectable glucocorticoids (prednisone 5 mg/day for at least three months) It is also used in the treatment of osteoporosis associated with the use of other corticosteroids at equivalent doses). Using FORSTEO with food and drink, FORSTEO can be used on an empty or full stomach.
There is no comment for this product, yet.